{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:13:16Z","timestamp":1771661596466,"version":"3.50.1"},"reference-count":28,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T00:00:00Z","timestamp":1489017600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T00:00:00Z","timestamp":1489017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1111\/jcpt.12509","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T09:43:08Z","timestamp":1489052588000},"page":"286-291","source":"Crossref","is-referenced-by-count":18,"title":["A retrospective evaluation of furosemide and mannitol for prevention of cisplatin-induced nephrotoxicity"],"prefix":"10.1155","volume":"42","author":[{"given":"C. M.","family":"Mach","sequence":"first","affiliation":[{"name":"College of Pharmacy; University of Houston; Houston TX USA"},{"name":"Department of Obstetrics and Gynecology; Baylor College of Medicine; Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kha","sequence":"additional","affiliation":[{"name":"College of Pharmacy; University of Houston; Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"College of Pharmacy; University of Houston; Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Shumway","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology; Baylor College of Medicine; Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. M.","family":"Meaders","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology; Baylor College of Medicine; Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ludwig","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology; Baylor College of Medicine; Houston TX USA"},{"name":"Dan L. Duncan Cancer Center; Baylor College of Medicine; Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Y.","family":"Williams-Brown","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology; Baylor College of Medicine; Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2081-4672","authenticated-orcid":false,"given":"M. L.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology; Baylor College of Medicine; Houston TX USA"},{"name":"Dan L. Duncan Cancer Center; Baylor College of Medicine; Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,3,9]]},"reference":[{"key":"10.1111\/jcpt.12509-BIB0001|jcpt12509-cit-0001","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12509-BIB0002|jcpt12509-cit-0002","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1111\/jcpt.12509-BIB0003|jcpt12509-cit-0003","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1200\/JCO.2006.09.4532","article-title":"Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study","volume":"25","author":"Rose","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1111\/jcpt.12509-BIB0004|jcpt12509-cit-0004","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int"},{"key":"10.1111\/jcpt.12509-BIB0005|jcpt12509-cit-0005","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<866::AID-IJC34>3.0.CO;2-9","article-title":"Platinum organ toxicity and possible prevention in patients with testicular cancer","volume":"83","author":"Hartmann","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1111\/jcpt.12509-BIB0006|jcpt12509-cit-0006","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/sj.ki.5002256","article-title":"The pathological role of Bax in cisplatin nephrotoxicity","volume":"72","author":"Wei","year":"2007","journal-title":"Kidney Int"},{"key":"10.1111\/jcpt.12509-BIB0007|jcpt12509-cit-0007","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","article-title":"Cisplatin nephrotoxicity","volume":"23","author":"Arany","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1111\/jcpt.12509-BIB0008|jcpt12509-cit-0008","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/1097-0142(197704)39:4<1362::AID-CNCR2820390403>3.0.CO;2-N","article-title":"The renal pathology in clinical trials of cis-platinum (II) diamminedichloride","volume":"39","author":"Gonzales-Vitale","year":"1977","journal-title":"Cancer"},{"key":"10.1111\/jcpt.12509-BIB0009|jcpt12509-cit-0009","first-page":"151","article-title":"Cisplatin nephrotoxicity: symptomatic hypomagnesemia and renal failure","volume":"7","author":"Gomez Campdera","year":"1986","journal-title":"Int J Pediatr Nephrol"},{"key":"10.1111\/jcpt.12509-BIB0010|jcpt12509-cit-0010","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1177\/1060028014533303","article-title":"Rates of renal toxicity in cancer patients receiving cisplatin with and without mannitol","volume":"48","author":"Morgan","year":"2014","journal-title":"Ann Pharmacother"},{"key":"10.1111\/jcpt.12509-BIB0011|jcpt12509-cit-0011","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF00258455","article-title":"Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum","volume":"23","author":"Dumas","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1111\/jcpt.12509-BIB0012|jcpt12509-cit-0012","first-page":"31","article-title":"Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study","volume":"66","author":"Al-Sarraf","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"10.1111\/jcpt.12509-BIB0013|jcpt12509-cit-0013","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1345\/aph.1Q333","article-title":"The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy","volume":"46","author":"Morgan","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1111\/jcpt.12509-BIB0014|jcpt12509-cit-0014","first-page":"562","article-title":"Hydration with magnesium and mannitol without furosemide prevents the nephrotoxicity induced by cisplatin and pemetrexed in patients with advanced non-small cell lung cancer","volume":"4","author":"Muraki","year":"2012","journal-title":"J Thorac Dis"},{"key":"10.1111\/jcpt.12509-BIB0015|jcpt12509-cit-0015","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/2050-6511-15-70","article-title":"Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study","volume":"15","author":"Oka","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1111\/jcpt.12509-BIB0016|jcpt12509-cit-0016","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00280-003-0620-1","article-title":"Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial","volume":"52","author":"Santoso","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1111\/jcpt.12509-BIB0017|jcpt12509-cit-0017","first-page":"73","article-title":"High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity","volume":"65","author":"Ostrow","year":"1981","journal-title":"Cancer Treat Rep"},{"key":"10.1111\/jcpt.12509-BIB0018|jcpt12509-cit-0018","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00520-015-2978-0","article-title":"Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy","volume":"24","author":"McKibbin","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1111\/jcpt.12509-BIB0019|jcpt12509-cit-0019","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/jcpt.12509-BIB0020|jcpt12509-cit-0020","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","article-title":"Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values","volume":"53","author":"Levey","year":"2007","journal-title":"Clin Chem"},{"key":"10.1111\/jcpt.12509-BIB0021|jcpt12509-cit-0021","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijrobp.2007.05.028","article-title":"Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment","volume":"70","author":"Torres","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/jcpt.12509-BIB0022|jcpt12509-cit-0022","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/1078155209346071","article-title":"A comparison of the rates of cisplatin (cDDP)-induced nephrotoxicity associated with sodium loading or sodium loading with forced diuresis as a preventative measure","volume":"16","author":"Leu","year":"2010","journal-title":"J Oncol Pharm Pract"},{"key":"10.1111\/jcpt.12509-BIB0023|jcpt12509-cit-0023","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12640-011-9244-0","article-title":"Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice","volume":"20","author":"Li","year":"2011","journal-title":"Neurotox Res"},{"key":"10.1111\/jcpt.12509-BIB0024|jcpt12509-cit-0024","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/archinte.1996.00440100029005","article-title":"Hypomagnesemia and diabetes mellitus. A review of clinical implications","volume":"156","author":"Tosiello","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1111\/jcpt.12509-BIB0025|jcpt12509-cit-0025","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1001\/jama.1992.03480080053026","article-title":"Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men","volume":"267","author":"Siegel","year":"1992","journal-title":"JAMA"},{"key":"10.1111\/jcpt.12509-BIB0026|jcpt12509-cit-0026","first-page":"58","article-title":"Serum magnesium levels in patients with alcoholic and non-alcoholic fatty liver","volume":"107","author":"Turecky","year":"2006","journal-title":"Bratisl Lek Listy"},{"key":"10.1111\/jcpt.12509-BIB0027|jcpt12509-cit-0027","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1034\/j.1399-0012.2002.01141.x","article-title":"Magnesium depletion in chronic terminal liver cirrhosis","volume":"16","author":"Turecky","year":"2002","journal-title":"Clin Transplant"},{"key":"10.1111\/jcpt.12509-BIB0028|jcpt12509-cit-0028","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0885066604271539","article-title":"Magnesium deficiency in critical illness","volume":"20","author":"Tong","year":"2005","journal-title":"J Intensive Care Med"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12509","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12509\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:02:39Z","timestamp":1671818559000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12509","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3,9]]}}}